175 related articles for article (PubMed ID: 3619586)
1. [Double-blind study of the efficacy of an antiserotoninergic drug, pizotifen, in Duchenne's muscular dystrophy].
Steru D; Paclet JP; Barthelet G; Gailliard G; Piton A; Monchartre E; Roche R; Galli J; Lancrenon S; Fermanian J
Arch Fr Pediatr; 1987; 44(6):461-5. PubMed ID: 3619586
[TBL] [Abstract][Full Text] [Related]
2. [Ineffectiveness of diltiazem in Duchenne muscular dystrophy: a placebo-controlled double-blind study].
Toifl K; Presterl E; Graninger W
Wien Klin Wochenschr; 1991; 103(8):232-5. PubMed ID: 1907056
[TBL] [Abstract][Full Text] [Related]
3. [A therapeutic trial of mazindol versus placebo in Duchenne muscular dystrophy. A one-year follow-up study of 14 children].
Desnuelle C; Serratrice G; N'guyen VK; Richelme C; Pinsard N
Arch Fr Pediatr; 1989 Dec; 46(10):759-65. PubMed ID: 2697199
[TBL] [Abstract][Full Text] [Related]
4. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy.
Mendell JR; Moxley RT; Griggs RC; Brooke MH; Fenichel GM; Miller JP; King W; Signore L; Pandya S; Florence J
N Engl J Med; 1989 Jun; 320(24):1592-7. PubMed ID: 2657428
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic trial with allopurinol in progressive muscular dystrophy (author's transl)].
Pineda M; Fábregues I; Campistol J; Fernández Alvarez E; Alvarez M
An Esp Pediatr; 1982 Jan; 16(1):42-6. PubMed ID: 7044206
[TBL] [Abstract][Full Text] [Related]
6. Lack of benefit of allopurinol in Duchenne dystrophy.
Mendell JR; Wiechers DO
Muscle Nerve; 1979; 2(1):53-6. PubMed ID: 397411
[TBL] [Abstract][Full Text] [Related]
7. [Double-blind clinical study: flunarizine versus pizotifen in a single nightly dose in hemicrania patients].
Cerbo R; Casacchia M; Formisano R; Buzzi MG; Boni B; Feliciani M; Grillo G; Cusimano G; Agnoli A
Riv Neurol; 1985; 55(2):139-46. PubMed ID: 4012191
[TBL] [Abstract][Full Text] [Related]
8. Clinical investigation in Duchenne muscular dystrophy: IV. Double-blind controlled trial of leucine.
Mendell JR; Griggs RC; Moxley RT; Fenichel GM; Brooke MH; Miller JP; Province MA; Dodson WE
Muscle Nerve; 1984 Sep; 7(7):535-41. PubMed ID: 6399927
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind trial of mazindol in Duchenne dystrophy.
Griggs RC; Moxley RT; Mendell JR; Fenichel GM; Brooke MH; Miller PJ; Mandel S; Florence J; Schierbecker J; Kaiser KK
Muscle Nerve; 1990 Dec; 13(12):1169-73. PubMed ID: 2266990
[TBL] [Abstract][Full Text] [Related]
10. CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.
Escolar DM; Buyse G; Henricson E; Leshner R; Florence J; Mayhew J; Tesi-Rocha C; Gorni K; Pasquali L; Patel KM; McCarter R; Huang J; Mayhew T; Bertorini T; Carlo J; Connolly AM; Clemens PR; Goemans N; Iannaccone ST; Igarashi M; Nevo Y; Pestronk A; Subramony SH; Vedanarayanan VV; Wessel H;
Ann Neurol; 2005 Jul; 58(1):151-5. PubMed ID: 15984021
[TBL] [Abstract][Full Text] [Related]
11. Clinical investigation in Duchenne dystrophy. VI. Double-blind controlled trial of nifedipine.
Moxley RT; Brooke MH; Fenichel GM; Mendell JR; Griggs RC; Miller JP; Province MA; Patterson V
Muscle Nerve; 1987 Jan; 10(1):22-33. PubMed ID: 3550455
[TBL] [Abstract][Full Text] [Related]
12. Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E.
Fenichel GM; Brooke MH; Griggs RC; Mendell JR; Miller JP; Moxley RT; Park JH; Provine MA; Florence J; Kaiser KK
Muscle Nerve; 1988 Nov; 11(11):1164-8. PubMed ID: 3067086
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Duchenne muscular dystrophy with growth hormone inhibitors.
Zatz M; Betti RT; Frota-Pessoa O
Am J Med Genet; 1986 Jul; 24(3):549-66. PubMed ID: 3524231
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials of vasoactive and antiserotonin drugs in Duchenne muscular dystrophy.
Patten BM; Zeller RS
Ann Clin Res; 1983 Aug; 15(4):164-6. PubMed ID: 6360027
[TBL] [Abstract][Full Text] [Related]
15. Intellectual function in Duchenne muscular dystrophy: the influence of penicillamine.
Buchanan DC; Roelofs RI; White DK; Saavedra de Arango G
Arch Phys Med Rehabil; 1981 Dec; 62(12):623-5. PubMed ID: 7032457
[TBL] [Abstract][Full Text] [Related]
16. A trial of flunarizine in the treatment of Duchenne muscular dystrophy.
Dick DJ; Gardner-Medwin D; Gates PG; Gibson M; Simpson JM; Walls TJ
Muscle Nerve; 1986 May; 9(4):349-54. PubMed ID: 3520308
[TBL] [Abstract][Full Text] [Related]
17. Drug trial of superoxide dismutase in Duchenne's muscular dystrophy.
Stern LZ; Ringel SP; Ziter FA; Menander-Huber KB; Ionasescu V; Pellegrino RJ; Snyder RD
Arch Neurol; 1982 Jun; 39(6):342-6. PubMed ID: 7046702
[TBL] [Abstract][Full Text] [Related]
18. Pizotifen in the management of migraine.
Bademosi O; Osuntokun BO
Practitioner; 1978 Feb; 220(1316):325-7. PubMed ID: 345259
[No Abstract] [Full Text] [Related]
19. Pizotifen (Sanomigran) in childhood migraine. A double-blind controlled trial.
Gillies D; Sills M; Forsythe I
Eur Neurol; 1986; 25(1):32-5. PubMed ID: 3510125
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic trial of isaxonine in Duchenne muscular dystrophy.
Heckmatt JZ; Hyde SA; Gabain A; Dubowitz V
Muscle Nerve; 1988 Aug; 11(8):836-47. PubMed ID: 3050510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
